Fate Therapeutics, Inc. (FATE)
2.32
+0.02
(+0.87%)
USD |
NASDAQ |
Oct 02, 16:00
2.29
-0.03
(-1.29%)
Pre-Market: 20:00
Fate Therapeutics Max Drawdown (5Y) : 99.42% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.42% |
| August 31, 2026 | 99.42% |
| July 31, 2026 | 99.42% |
| June 30, 2026 | 99.42% |
| May 31, 2026 | 99.42% |
| April 30, 2026 | 99.42% |
| March 31, 2026 | 99.42% |
| February 28, 2026 | 99.42% |
| January 31, 2026 | 99.42% |
| December 31, 2025 | 99.42% |
| November 30, 2025 | 99.42% |
| October 31, 2025 | 99.42% |
| September 30, 2025 | 99.42% |
| August 31, 2025 | 99.42% |
| July 31, 2025 | 99.42% |
| June 30, 2025 | 99.42% |
| May 31, 2025 | 99.42% |
| April 30, 2025 | 99.42% |
| March 31, 2025 | 99.33% |
| February 28, 2025 | 99.07% |
| January 31, 2025 | 98.94% |
| December 31, 2024 | 98.63% |
| November 30, 2024 | 98.59% |
| October 31, 2024 | 98.59% |
| September 30, 2024 | 98.59% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.59% |
| July 31, 2024 | 98.59% |
| June 30, 2024 | 98.59% |
| May 31, 2024 | 98.59% |
| April 30, 2024 | 98.59% |
| March 31, 2024 | 98.59% |
| February 29, 2024 | 98.59% |
| January 31, 2024 | 98.59% |
| December 31, 2023 | 98.59% |
| November 30, 2023 | 98.59% |
| October 31, 2023 | 98.59% |
| September 30, 2023 | 98.28% |
| August 31, 2023 | 97.86% |
| July 31, 2023 | 96.51% |
| June 30, 2023 | 96.39% |
| May 31, 2023 | 96.39% |
| April 30, 2023 | 96.39% |
| March 31, 2023 | 96.39% |
| February 28, 2023 | 96.39% |
| January 31, 2023 | 96.39% |
| December 31, 2022 | 91.60% |
| November 30, 2022 | 84.86% |
| October 31, 2022 | 84.86% |
| September 30, 2022 | 84.86% |
| August 31, 2022 | 84.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agenus, Inc. | 98.84% |
| Amgen, Inc. | 24.86% |
| BioCryst Pharmaceuticals, Inc. | 79.10% |
| Imunon, Inc. | 99.49% |
| Curis, Inc. | 99.98% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -76.49 |
| Beta (5Y) | 2.521 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.37% |
| Historical Sharpe Ratio (5Y) | -0.5319 |
| Historical Sortino (5Y) | -1.146 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.02% |